Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) – Global Forecast to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 26, 2020
Clear
SKU: GMS-1153 Category:

The point-of-care diagnostic market size is projected to reach USD 47.12 billion by 2024, growing at 10.32% CAGR. The growth of the market is driven by factors such as the high prevalence of infectious diseases, increasing incidence of target conditions and increasing preference for home healthcare worldwide.

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 1

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 2

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 3

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 4

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 5

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 6

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 7

Point of Care Diagnostics Market by Product (Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation, Glucose), Platform (Immunoassays, Microfluidics), Mode (OTC, Prescription), End-User (Home Care, Hospitals) - Global Forecast to 2024 8

1 Global Point of Care Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Point of Care Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Point of Care Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Point of Care Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Point of Care Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Point of Care Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Point of Care Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Glucose Monitoring Products
8.2 Infectious Disease Testing Products
8.3 Coagulation Monitoring Products
8.4 Cardiometabolic Monitoring Products
8.5 Pregnancy & Fertility Testing Products
8.6 Others

9 Global Point of Care Diagnostics Market – By Platform
9.1 Lateral Flow Assays
9.2 Dipsticks
9.3 Molecular Diagnostics
9.4 Microfluidics
9.5 Immunoassays

10 Global Point of Care Diagnostics Market – By Mode of Purchase
10.1 Prescription-Based Products
10.2 OTC Products

11 Global Point of Care Diagnostics Market – By End User
11.1 Professional Diagnostic Centers
11.2 Hospitals/Critical Care Centers
11.3 Home Care Settings
11.4 Research Laboratories

12 Global Point of Care Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Point of Care Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Point of Care Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Abbott Laboratories
14.3 Becton, Dickinson, and Company (BD)
14.4 Chembio Diagnostics
14.5 Danaher Corporation
14.6 Johnson & Johnson
14.7 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
14.8 Siemens Healthineers Group
14.9 EKF Diagnostics
14.10 Quidel
14.11 Trinity Biotech
14.12 Company 11 & more

15 Global Point of Care Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations